Showing 2 posts of 2 posts found.
Johnson & Johnson has suffered a blow after the FDA strengthened its safety warning for the company’s type 2 diabetes …
The FDA has issued a safety alert, warning of joint pain caused by the gliptins, a common class of drugs …
Lonza and Engitix partner to develop next-generation antibody-drug conjugates
Simris Group appoints Tiffany J Vora as Strategic Advisor
Cizzle Biotechnology expands US rollout of lung cancer blood test
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide